A follow-on study on vision-related quality of life assessment using the NEI-VFQ-25 in those with a history of unilateral and bilateral congenital cataracts.

Purpose: To assess vision-specific health-related quality of life (using the NEI-VFQ-25), educational attainment and visual acuity (VA) in patients with a history of congenital cataracts and appraise these in relation to Kirwan et al.'s (Pediatr Ophthalmol Strabismus 49, 2012, 26) study.

Methods: A retrospective hospital-based study of patients with unilateral and bilateral congenital cataracts whounderwent surgery aged younger than 12 months.

Bevacizumab compared with diode laser in stage 3 posterior retinopathy of prematurity: A 5 year follow up.

We conducted a prospective randomized study to compare outcomes of intravitreal Bevacizumab versus diode laser in thirty eyes of fifteen premature babies with zone 1 or posterior zone 2 retinopathy of prematurity (ROP). We recorded complications, regression/reactivation of ROP, visual outcome, refractive error and systemic complications. The Bevacizumab treated eyes showed rapid regression of the ROP with resolution of plus disease and flattening of the ridge at 48 hours post injection.

An ocular motility conundrum.

Two siblings, an 11-year-old boy and a 7-year-old girl presented with bilateral symmetrical ptosis and limited eye movements. Having already been reviewed on a number of occasions by a variety of specialists in multiple hospital settings a diagnosis of their ocular motility disorder had remained elusive. We describe their cases, outline the differential diagnosis and review the investigations performed which were influential in finally making a diagnosis.